Identifying Determinants Of Both The Origins And The Progression Of The Depressive And Bipolar (mood) Disorders.
Funder
National Health and Medical Research Council
Funding Amount
$6,235,352.00
Summary
Currently, mood disorders are classified by severity, largely ignoring causes and leading to limited treatments. The Team will clarify how differing depressive and bipolar (mood) disorders are best modelled and pursue their differing causes, so assisting identification of specific treatments relating to their underlying causes. Our studies employ a range of sophisticated technologies, including molecular biology, brain imaging techniques, and mathematical modeling. The capacity of such research ....Currently, mood disorders are classified by severity, largely ignoring causes and leading to limited treatments. The Team will clarify how differing depressive and bipolar (mood) disorders are best modelled and pursue their differing causes, so assisting identification of specific treatments relating to their underlying causes. Our studies employ a range of sophisticated technologies, including molecular biology, brain imaging techniques, and mathematical modeling. The capacity of such research to advance the management of mood disorders address a pressing clinical need.Read moreRead less
Multivariate Whole Genome Estimation And Prediction Analysis Of Genomics Data Applied To Psychiatric Disorders
Funder
National Health and Medical Research Council
Funding Amount
$639,582.00
Summary
We have made major contributions to the development of statistical methods applied to data from the international Psychiatric Genomics Consortium. Major new data sets will soon become available, with immense sample sizes (100,000s) and more extensive clinical and environmental data. We will develop and apply novel statistical analyses of these data, to answer fundamental questions about the genetic basis of psychiatric disorders and the interplay of genetic and environmental risk factors.
A Prospective Study Of Inflammatory Cytokines As Common Factors In The Aetiology Of Both Depression And Osteoporosis.
Funder
National Health and Medical Research Council
Funding Amount
$291,230.00
Summary
Both depression and osteoporosis are common, debilitating and expensive diseases and there is research to suggest that these conditions are related. This study will examine a potential common mechanism, inflammation, which may underlie both diseases. It will focus on circulating proteins which are associated with both depression and fragility fractures, and examine the role they play in both disorders.
Inflammatory Cytokines As Risk Factors For The Development Of Both Depression And Osteoporosis In Men
Funder
National Health and Medical Research Council
Funding Amount
$381,091.00
Summary
Both depression and osteoporosis impose a substantial public health burden on society and there is now research to suggest that these conditions are related. This study will examine a potential common mechanism, systemic inflammation, which may underlie both diseases. It will focus on markers of systemic inflammation, examine their association to both depression and bone fragility and determine what role they play in explaining the relationship between the disorders.
A Healthy Start To Life, Preventative Healthcare, Strengthening Australias Social Economic Fabric
Funder
National Health and Medical Research Council
Funding Amount
$4,000,000.00
Summary
The aim is to make a major contribution to the reduction of non-fatal disease burden internationally due to mental disorders and related alcohol and substance abuse through population-based research and development health strategies. Current estimates of avertable burden for mental disorders suggest that while 40% of the burden can be reduced by optimal implementation of currently available interventions another 60% will remain unavertable without new knowledge. That new knowledge includes not o ....The aim is to make a major contribution to the reduction of non-fatal disease burden internationally due to mental disorders and related alcohol and substance abuse through population-based research and development health strategies. Current estimates of avertable burden for mental disorders suggest that while 40% of the burden can be reduced by optimal implementation of currently available interventions another 60% will remain unavertable without new knowledge. That new knowledge includes not only that derived from novel or basic neurosciences but also clear determination as to whether currently proposed early intervention paradigms for young persons with mental disorders deliver sustained benefits. To ensure the maximum benefit for persons with mental disorders, Professor Hickie needs to engage directly in two major streams of activity. The first (75% of research effort) lies in maximising the chances that the health services and other population health activities that he has championed so actively over the last decade are now utilised to both advance knowledge as well as make a much greater contribution to actual reduction in illness burden. The second (25% of research effort) lies in maximising the specific international skills collected within the BMRI and distributed more widely in its local, national and international research networks. Mental Health Research desperately needs new basic science, translational and clinical knowledge and the combination of an Australian Fellowship and these networks would provide the environment for maximising the chances of achieving such real knowledge breakthroughsRead moreRead less
A Large-scale Clinical Effectiveness (health Services) Trial To Determine Whether Personalised Health Care Packages, Combined With Digitally-supported Measurement-based Care, Improve Functional Outcomes In Young People With Mood Disorders
Funder
National Health and Medical Research Council
Funding Amount
$3,434,588.00
Summary
One of our greatest current health challenges is to develop highly-personalised interventions for teenagers and young adults with emerging mood disorders. This research will combine our national expertise to develop and implement care packages utilising digital technologies, personalised assessment techniques, targeted treatment choices, and long-term outcome tracking. In a clinical trial we will assess the clinical effectiveness of these innovative healthcare packages.
Australasian Partnership For Improving Outcomes In Severe Depression
Funder
National Health and Medical Research Council
Funding Amount
$909,752.00
Summary
This 5-year project examines how proven treatments are used in real-world clinical practice, and how this can be improved. The project focuses on important physical interventions for depression: Electroconvulsive therapy (ECT), Ketamine, repetitive Transcranial Magnetic Stimulation (rTMS), transcranial Direct Current Stimulation (tDCS). The use of ECT to treat schizophrenia will also be examined. The research team will partner with clinical service providers and a government health department.
Defining The Function Of Two Discrete Precursor Cell Populations In The Adult Hippocampus: Potential For The Treatment Of Cognitive And Mood Disorders
Funder
National Health and Medical Research Council
Funding Amount
$578,985.00
Summary
Adult hippocampal neurogenesis plays a crucial role in fundamental cognitive processes such as learning and memory formation and mood regulation. Our laboratory has identified two discrete pools of quiescent stem and precursor cells in the adult hippocampus that can be activated by distinct mechanisms. This study will examine the functional properties of new neurons generated from these discrete pools and their role in improving behavioural outcomes associated with cognition and mood regulation